
|Videos|December 19, 2012
FDA Ruling on Statin Therapy
A discussion of an FDA warning regarding the potential for cognitive problems and elevated blood sugar associated with taking statins.
Advertisement
In this video, David Dichek, MD, of the University of Washington Medical Center, discusses an FDA warning regarding the potential for cognitive problems and elevated blood sugar associated with taking statins. He also discusses how to address concerns that patients may have about taking statins in light of the waning.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
2
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
3
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































